Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 242

1.

Ethical issues in denial of church wedding based on couple's hemoglobin genotype in Enugu, south eastern Nigeria.

Ezugwu EC, Osamor PE, Wendler D.

BMC Med Ethics. 2019 May 29;20(1):37. doi: 10.1186/s12910-019-0376-8.

2.

The Potential Benefits of Research May Justify Certain Research Risks.

Wendler D, Nelson RM, Lantos JD.

Pediatrics. 2019 Mar;143(3). pii: e20181703. doi: 10.1542/peds.2018-1703. Epub 2019 Feb 20.

PMID:
30787097
3.

Racial/Ethnic Differences in Comprehension of Biospecimen Collection: a Nationwide University of Rochester Cancer Center NCI Community Oncology Research Program Study.

Asare M, Heckler CE, Culakova E, Kamen CS, Kleckner AS, Minasian LM, Wendler DS, Feige M, Weil CJ, Long J, Cole SK, Onitilo AA, Peppone LJ, Morrow GR, Janelsins MC.

J Cancer Educ. 2019 Jan 5. doi: 10.1007/s13187-018-1464-z. [Epub ahead of print]

PMID:
30612315
4.

Are we meeting the informational needs of cancer patients and families? Perception of physician communication in pediatric oncology.

Levine DR, Liederbach E, Johnson LM, Kaye EC, Spraker-Perlman H, Mandrell B, Pritchard M, Sykes A, Lu Z, Wendler D, Baker JN.

Cancer. 2019 May 1;125(9):1518-1526. doi: 10.1002/cncr.31937. Epub 2019 Jan 2.

PMID:
30602057
5.

Locating the Source(s) of the Social Value Requirement(s).

Wendler D.

Hastings Cent Rep. 2018 Nov;48(6):33-35. doi: 10.1002/hast.935.

PMID:
30586177
6.

The Value in Doing Something.

Wendler D.

Crit Care Med. 2019 Feb;47(2):149-151. doi: 10.1097/CCM.0000000000003503.

PMID:
30334821
7.

Understanding preferences regarding consent for pragmatic trials in acute care.

Dickert NW, Wendler D, Devireddy CM, Goldkind SF, Ko YA, Speight CD, Kim SY.

Clin Trials. 2018 Dec;15(6):567-578. doi: 10.1177/1740774518801007. Epub 2018 Oct 3.

PMID:
30280582
8.

Reconsidering the Need for Reconsent at 18.

Berkman BE, Howard D, Wendler D.

Pediatrics. 2018 Aug;142(2). pii: e20171202. doi: 10.1542/peds.2017-1202. Epub 2018 Jul 6. Review.

9.

Using mobile location data in biomedical research while preserving privacy.

Goldenholz DM, Goldenholz SR, Krishnamurthy KB, Halamka J, Karp B, Tyburski M, Wendler D, Moss R, Preston KL, Theodore W.

J Am Med Inform Assoc. 2018 Oct 1;25(10):1402-1406. doi: 10.1093/jamia/ocy071.

10.

When Research Regulations and Ethics Conflict.

Sullivan HK, Braverman DW, Wendler D.

Am J Bioeth. 2018 Apr;18(4):96-97. doi: 10.1080/15265161.2018.1431706. No abstract available.

PMID:
29621439
11.

Consent for Pragmatic Trials in Acute Myocardial Infarction.

Dickert NW, Wendler D, Devireddy CM, Goldkind SF, Ko YA, Speight CD, Kim SYH.

J Am Coll Cardiol. 2018 Mar 6;71(9):1051-1053. doi: 10.1016/j.jacc.2017.12.043. No abstract available.

12.

Broad Consent for Research on Biospecimens: The Views of Actual Donors at Four U.S. Medical Centers.

Warner TD, Weil CJ, Andry C, Degenholtz HB, Parker L, Carithers LJ, Feige M, Wendler D, Pentz RD.

J Empir Res Hum Res Ethics. 2018 Apr;13(2):115-124. doi: 10.1177/1556264617751204. Epub 2018 Feb 1.

13.

Innovative approaches to informed consent for randomized clinical trials: Identifying the ethical challenges.

Wendler D.

Clin Trials. 2018 Feb;15(1):17-20. doi: 10.1177/1740774517746621. Epub 2017 Dec 17. No abstract available.

14.

Reframing Consent for Clinical Research: A Function-Based Approach.

Dickert NW, Eyal N, Goldkind SF, Grady C, Joffe S, Lo B, Miller FG, Pentz RD, Silbergleit R, Weinfurt KP, Wendler D, Kim SYH.

Am J Bioeth. 2017 Dec;17(12):3-11. doi: 10.1080/15265161.2017.1388448.

PMID:
29148951
15.

Is it important to disclose how treatments are selected in clinical research and clinical care?

Nayak RK, Wendler D.

AJOB Empir Bioeth. 2017 Jul-Sep;8(3):170-177. doi: 10.1080/23294515.2017.1314392. Epub 2017 Apr 3.

PMID:
28949900
16.
17.

Patients' beliefs regarding informed consent for low-risk pragmatic trials.

Dal-Ré R, Carcas AJ, Carné X, Wendler D.

BMC Med Res Methodol. 2017 Sep 18;17(1):145. doi: 10.1186/s12874-017-0424-3.

18.

A pragmatic analysis of vulnerability in clinical research.

Wendler D.

Bioethics. 2017 Sep;31(7):515-525. doi: 10.1111/bioe.12367.

19.

A Proposed Process for Reliably Updating the Common Rule.

Berkman BE, Wendler D, Sullivan HK, Grady C.

Am J Bioeth. 2017 Jul;17(7):8-14. doi: 10.1080/15265161.2017.1329478.

20.

Comparative effectiveness research: what to do when experts disagree about risks.

Lie RK, Chan FKL, Grady C, Ng VH, Wendler D.

BMC Med Ethics. 2017 Jun 19;18(1):42. doi: 10.1186/s12910-017-0202-0.

21.

Public preferences on written informed consent for low-risk pragmatic clinical trials in Spain.

Dal-Ré R, Carcas AJ, Carné X, Wendler D.

Br J Clin Pharmacol. 2017 Sep;83(9):1921-1931. doi: 10.1111/bcp.13305. Epub 2017 Jun 11.

22.

Temporally precise labeling and control of neuromodulatory circuits in the mammalian brain.

Lee D, Creed M, Jung K, Stefanelli T, Wendler DJ, Oh WC, Mignocchi NL, Lüscher C, Kwon HB.

Nat Methods. 2017 May;14(5):495-503. doi: 10.1038/nmeth.4234. Epub 2017 Apr 3.

PMID:
28369042
23.

Patients' and Parents' Needs, Attitudes, and Perceptions About Early Palliative Care Integration in Pediatric Oncology.

Levine DR, Mandrell BN, Sykes A, Pritchard M, Gibson D, Symons HJ, Wendler D, Baker JN.

JAMA Oncol. 2017 Sep 1;3(9):1214-1220. doi: 10.1001/jamaoncol.2017.0368.

24.

The Guinea Phase III Ebola Vaccine Trial: Lessons for Research Ethics Review in Public Health Emergencies.

Lie RK, Wendler D.

IRB. 2017 Mar-Apr;39(2):1- 7. No abstract available.

PMID:
30148330
25.

Why is Coerced Consent Worse Than No Consent and Deceived Consent?

Wendler D, Wertheimer A.

J Med Philos. 2017 Apr 1;42(2):114-131. doi: 10.1093/jmp/jhw064.

26.

The Theory and Practice of Surrogate Decision-Making.

Wendler D.

Hastings Cent Rep. 2017 Jan;47(1):29-31. doi: 10.1002/hast.671.

PMID:
28074586
27.

In Defense of a Social Value Requirement for Clinical Research.

Wendler D, Rid A.

Bioethics. 2017 Feb;31(2):77-86. doi: 10.1111/bioe.12325.

28.

Ensuring Respect for Human Research Participants: Institutional Review Boards and Sharing Results From Research.

Doernberg SN, Wendler D.

JAMA. 2016 Sep 20;316(11):1149-1150. doi: 10.1001/jama.2016.7970. No abstract available.

PMID:
27654597
29.

Is the French clinical trials regulation discriminatory?

Dal-Ré R, Wendler D.

Eur J Intern Med. 2016 Oct;34:e35-e36. doi: 10.1016/j.ejim.2016.07.019. Epub 2016 Aug 9. No abstract available.

PMID:
27519816
30.

Targeted Consent for Research on Standard of Care Interventions in the Emergency Setting.

Wendler D, Dickert NW, Silbergleit R, Kim SY, Brown J.

Crit Care Med. 2017 Jan;45(1):e105-e110.

31.

Addressing exploitation of poor clinical trial participants in North America and the European Union.

Dal-Ré R, Rid A, Emanuel E, Wendler D.

Eur J Intern Med. 2016 Oct;34:e37-e38. doi: 10.1016/j.ejim.2016.06.026. Epub 2016 Jul 15. No abstract available.

PMID:
27425655
32.

The Potential for Infrastructure Benefits and the Responsiveness Requirement.

Wendler D.

Am J Bioeth. 2016 Jun;16(6):1-2. doi: 10.1080/15265161.2016.1184508. No abstract available.

PMID:
27216088
33.

When clinical care is like research: the need for review and consent.

Wendler D, Johnson R.

Theor Med Bioeth. 2016 Jun;37(3):193-209. doi: 10.1007/s11017-016-9364-x.

PMID:
27188333
34.

Adolescent Research Participants' Descriptions of Medical Research.

Grady C, Nogues I, Wiener L, Wilfond BS, Wendler D.

AJOB Empir Bioeth. 2016 Jan 1;7(1):1-7. Epub 2015 Feb 19.

35.

Small-Molecule CD4-Mimics: Structure-Based Optimization of HIV-1 Entry Inhibition.

Melillo B, Liang S, Park J, Schön A, Courter JR, LaLonde JM, Wendler DJ, Princiotto AM, Seaman MS, Freire E, Sodroski J, Madani N, Hendrickson WA, Smith AB 3rd.

ACS Med Chem Lett. 2016 Jan 19;7(3):330-4. doi: 10.1021/acsmedchemlett.5b00471. eCollection 2016 Mar 10.

36.

Research involving pediatric stem cell donors: A way forward.

Wendler D, Shah NN, Pulsipher MA, Fry T, Grady C.

Clin Trials. 2016 Jun;13(3):304-10. doi: 10.1177/1740774515627156. Epub 2016 Feb 17.

37.

A new method for making treatment decisions for incapacitated patients: what do patients think about the use of a patient preference predictor?

Wendler D, Wesley B, Pavlick M, Rid A.

J Med Ethics. 2016 Apr;42(4):235-41. doi: 10.1136/medethics-2015-103001. Epub 2016 Jan 29.

PMID:
26825474
38.

The potential exploitation of research participants in high income countries who lack access to health care.

Dal-Ré R, Rid A, Emanuel E, Wendler D.

Br J Clin Pharmacol. 2016 May;81(5):857-64. doi: 10.1111/bcp.12879. Epub 2016 Feb 29. Review.

39.

Do Patients Want their Families or their Doctors to Make Treatment Decisions in the Event of Incapacity, and Why?

Wendler D, Wesley R, Pavlick M, Rid A.

AJOB Empir Bioeth. 2016;7(4):251-259. doi: 10.1080/23294515.2016.1182235. Epub 2016 Apr 26.

40.

Confronting Ethical and Regulatory Challenges of Emergency Care Research With Conscious Patients.

Dickert NW, Brown J, Cairns CB, Eaves-Leanos A, Goldkind SF, Kim SY, Nichol G, O'Conor KJ, Scott JD, Sinert R, Wendler D, Wright DW, Silbergleit R.

Ann Emerg Med. 2016 Apr;67(4):538-45. doi: 10.1016/j.annemergmed.2015.10.026. Epub 2015 Dec 18.

PMID:
26707358
41.

Acceptable Approaches to Enrolling Adults Who Cannot Consent in More Than Minimal Risk Research.

Danis M, Wendler D, Kim S.

Am J Bioeth. 2015;15(10):70-1. doi: 10.1080/15265161.2015.1075806. No abstract available.

42.

Challenging the Sanctity of Donorism: Patient Tissue Providers as Payment-Worthy Contributors.

Johnson RA, Wendler D.

Kennedy Inst Ethics J. 2015 Sep;25(3):291-333. doi: 10.1353/ken.2015.0021.

PMID:
26412739
43.

Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report.

Wherrett DK, Chiang JL, Delamater AM, DiMeglio LA, Gitelman SE, Gottlieb PA, Herold KC, Lovell DJ, Orchard TJ, Ryan CM, Schatz DA, Wendler DS, Greenbaum CJ; Type 1 Diabetes TrialNet Study Group.

Diabetes Care. 2015 Oct;38(10):1975-85. doi: 10.2337/dc15-1429. Review.

44.

Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials.

Lantos JD, Wendler D, Septimus E, Wahba S, Madigan R, Bliss G.

Clin Trials. 2015 Oct;12(5):485-93. doi: 10.1177/1740774515597687. Epub 2015 Sep 15.

45.

Is there a role for assent or dissent in animal research?

Kantin H, Wendler D.

Camb Q Healthc Ethics. 2015 Oct;24(4):459-72. doi: 10.1017/S0963180115000110.

PMID:
26364780
46.

Risks of phase I research with healthy participants: A systematic review.

Johnson RA, Rid A, Emanuel E, Wendler D.

Clin Trials. 2016 Apr;13(2):149-60. doi: 10.1177/1740774515602868. Epub 2015 Sep 8. Review.

47.

Broad Consent for Research With Biological Samples: Workshop Conclusions.

Grady C, Eckstein L, Berkman B, Brock D, Cook-Deegan R, Fullerton SM, Greely H, Hansson MG, Hull S, Kim S, Lo B, Pentz R, Rodriguez L, Weil C, Wilfond BS, Wendler D.

Am J Bioeth. 2015;15(9):34-42. doi: 10.1080/15265161.2015.1062162.

48.

Involving Communities in Deciding What Benefits They Receive in Multinational Research.

Wendler D, Shah S.

J Med Philos. 2015 Oct;40(5):584-600. doi: 10.1093/jmp/jhv017. Epub 2015 Jul 29.

49.

Clinical research: Should patients pay to play?

Emanuel EJ, Joffe S, Grady C, Wendler D, Persad G.

Sci Transl Med. 2015 Jul 29;7(298):298ps16. doi: 10.1126/scitranslmed.aac5204. Review.

PMID:
26223299
50.

Clarifying and defending the endorsed life approach to surrogate decision-making.

Phillips J, Wendler D.

J Med Ethics. 2015 Sep;41(9):736-8. doi: 10.1136/medethics-2015-102950. Epub 2015 Jul 28. No abstract available.

PMID:
26220990

Supplemental Content

Loading ...
Support Center